0001607062-22-000204.txt : 20220325 0001607062-22-000204.hdr.sgml : 20220325 20220324201732 ACCESSION NUMBER: 0001607062-22-000204 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20220321 ITEM INFORMATION: Entry into a Material Definitive Agreement ITEM INFORMATION: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant ITEM INFORMATION: Unregistered Sales of Equity Securities ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20220325 DATE AS OF CHANGE: 20220324 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NEUROPATHIX, INC. CENTRAL INDEX KEY: 0001615999 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 462645343 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-55657 FILM NUMBER: 22767962 BUSINESS ADDRESS: STREET 1: 3805 OLD EASTON ROAD CITY: DOYLESTOWN STATE: PA ZIP: 18902 BUSINESS PHONE: 858-883-2642 MAIL ADDRESS: STREET 1: 3805 OLD EASTON ROAD CITY: DOYLESTOWN STATE: PA ZIP: 18902 FORMER COMPANY: FORMER CONFORMED NAME: Neuropathix, Inc. DATE OF NAME CHANGE: 20201112 FORMER COMPANY: FORMER CONFORMED NAME: Kannalife Inc DATE OF NAME CHANGE: 20181113 FORMER COMPANY: FORMER CONFORMED NAME: TYG Solutions Corp. DATE OF NAME CHANGE: 20140821 8-K 1 nptx032422form8k.htm 8-K

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

_______________________

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of Earliest Event Reported): March 21, 2022

NEUROPATHIX, INC.

(Exact name of registrant as specified in its charter)

Delaware		000-55657		46-2645343
(State or other jurisdiction of incorporation)		(Commission File Number)		(I.R.S. Employer Identification No.)

3805 Old Easton Road, Doylestown, PA		18902
(Address of principal executive offices)		(Zip Code)

(858) 883-2642

(Registrant’s telephone number, including area code)

N/A

(Former name if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbols(s)	Name of each exchange on which registered
N/A

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

1

Item 1.01 Entry into a Material Definitive Agreement

On March 21, 2022, Neuropathix, Inc. (the "Company") issued three (3) convertible notes on identical terms to three private investors having an aggregate face value of $150,000 (the "Convertible Notes"). The Convertible Notes were issued in exchange for an aggregate of $150,000 cash received by the Company.

Each of the Convertible Notes is (i) unsecured; (ii) bears interest at a rate of 3% per annum; (iii) matures on March 21, 2032; and (iv) in the sole discretion of the holder, is convertible, in whole or in part, into restricted shares of the Company's common stock at a conversion price equal to the lesser of $0.01 or 70% of the average of the two (2) lowest closing prices of the Company’s common stock in the ten (10) trading days preceding any particular conversion, provided, the holder is prohibited from converting the convertible note, or portion thereof, if such conversion would result in beneficial ownership by the holder and its affiliates of more than 4.9% of Company’s issued and outstanding common stock as of the date of the conversion.

The foregoing summary of the Convertible Notes does not purport to be complete and is subject to, and qualified in its entirety, by reference to the form of Convertible Note attached hereto as Exhibits 10.1, which is incorporated herein by reference.

Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.

The information set forth in Item 1.01 of this Current Report on Form 8-K is incorporated herein by reference.

Item 3.02 Unregistered Sales of Equity Securities

The information set forth in Item 1.01 of this Current Report on Form 8-K is incorporated herein by reference.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

Exhibit

#

Description

10.1

Form of Convertible Note dated March 21, 2022.

104

Cover Page Interactive Data File – the cover page XBRL tags are embedded within the Inline XBRL Document

2

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	NEUROPATHIX, INC.

Dated: March 25, 2022	By:	/s/ Dean Petkanas
		Name: Dean Petkanas
		Chief Executive Officer

3

EX-10.1 2 ex10_1.htm EXHIBIT 10.1

Exhibit 10.1

CONVERTIBLE NOTE

$50,000

San Diego, California

March 21, 2022

FOR VALUE RECEIVED, the undersigned, Neuropathix, Inc., a Delaware corporation (“Debtor”), promises to pay to the order of [INVESTOR], a [ ], or order (“Holder”), at the corporate offices of Holder, or such other place as Holder may designate in writing, the principal amount of Fifty Thousand and 00/100 Dollars ($50,000), together with interest on the unpaid principal balance from time to time outstanding, computed on the basis of a three hundred sixty (360) day year and compounded on a yearly basis at a rate equal to Three Percent (3%) per annum (the “Interest Rate”).

1. Payment of Principal and Interest. From the date of this Convertible Note (the “Note” or “Convertible Note”), interest shall be payable annually beginning on March 21, 2023 until the maturity date of March 21, 2032, at which time all principal and interest accrued thereon shall be due and payable in United States currency.

2. Prepayment. Debtor shall not be permitted to prepay this Note, either in whole or in part, without the express written consent of Holder, which consent Holder may withhold in its sole and absolute discretion.

3. Conversion of Note.

(a) Any Holder of this Note has the right, at the Holder's option, at any time prior to payment in full of the principal balance of this Note, to convert this Note, in whole or in part, into fully paid and nonassessable shares of Debtor’s common stock ("Common Stock"). The number of shares of Common Stock into which this Note may be converted ("Conversion Shares") shall be determined by dividing the aggregate principal amount being tendered for conversion including interest accrued thereon (unless Holder elects to have the interest paid in cash) by the Conversion Price in effect at the time of such conversion. The Conversion Price shall be equal to the lesser of $0.01 or 70% of the average of the two lowest closing prices of Debtor's common stock in the ten (10) trading days prior to any particular conversion.

Notwithstanding the foregoing, Holder shall not be permitted to convert the Note, or portion thereof, if such conversion would result in beneficial ownership by Holder and its affiliates of more than 4.9% of the Debtor’s outstanding Common Stock as of the date of conversion.

(b) If Holder desires to exercise its conversion rights under this Note it may do so by delivering a conversion notice in similar form and substance as the conversion notice attached hereto as “Attachment 1” at the Debtor’s principal corporate office.

(c) No fractional shares shall be issued upon conversion. The amount of shares to be issued upon conversion shall be rounded to the nearest whole share amount.

(d) As promptly as practicable after the conversion of this Note, the Debtor at its expense will issue and deliver to Holder of this Note a certificate or certificates for the number of shares of Common Stock issuable upon such conversion.

4. Conversion Price Adjustments.

(a) In case at any time the Common Stock outstanding shall be combined into a lesser number of shares, whether by reclassification or reduction of capital stock, and whether referred to as a “reverse split” or otherwise (a “Share Reduction Event”), then the Conversion Price shall be proportionately increased by multiplying the Conversion Price immediately preceding a Share Reduction Event by the sum of (i) the number of shares of Common Stock outstanding immediately prior to a Share Reduction Event divided by (ii) the number of shares of Common Stock outstanding immediately following such Share Reduction Event.

(b) In case at any time any Common Stock shall be issued, or be deemed to have been issued, as a dividend on outstanding Common Stock or shall be issued upon subdivision, reclassification, recapitalization, whether referred to as a “stock split” or otherwise (a “Share Increase Event”), then the Conversion Price shall be proportionately decreased by multiplying the Conversion Price immediately preceding a Share Increase Event by the sum of (i) the number of shares of Common Stock outstanding immediately prior to a Share Increase Event divided by (ii) the number of shares of Common Stock outstanding immediately following such Share Increase Event.

5. Event of Default. Each of the following shall constitute an Event of Default under this Note:

(a) Debtor fails to make any payment when due on this Note or is in default on any other of its indebtedness that is evidenced by a promissory note (whether convertible or non-convertible) and either Debtor has not received a waiver of such default or the time to cure such default has lapsed.

(b) Upon any assignment by Debtor for the benefit of creditors, or filing by or against Debtor of a petition in bankruptcy, or adjudication of Debtor as bankrupt or insolvent, or filing by or against Debtor of any petition or answer seeking for Debtor any reorganization, arrangement, composition, readjustment, liquidation, dissolution or similar relief under any present or future statute, law or regulation, or filing any answer admitting or failing to deny the material allegations of a petition filed against it for any such relief, or seeking or consenting to or acquiescing in the appointment of any trustee, receiver or liquidator of itself or of all or any substantial part of its properties, or its directors or stockholders taking any action looking to its dissolution or liquidation.

6. Holder's Rights. Upon an Event of Default, Holder may declare the entire unpaid principal balance on this Convertible Note together with interest on any unpaid balance immediately due, without notice, and then Debtor will pay that amount.

If any Event of Default occurs, neither the failure of Holder to promptly exercise its right to declare the outstanding principal of and accrued and unpaid interest on this Convertible Note to be immediately due and payable, nor the failure of Holder to exercise any other right or remedy that it may have for default, nor the acceptance by Holder of late payments, nor the failure of Holder to demand strict performance of any obligation of Debtor hereunder, shall constitute a waiver of any such rights while such default continues, nor a waiver of such rights in connection with any future default on the part of Debtor. Furthermore, acceptance by Holder of partial payments following due acceleration of the indebtedness evidenced hereby shall not constitute a waiver by Holder of the acceleration of such indebtedness

7. Sale, Assignment or Transfer of Note. The Holder of this Convertible Note may sell, assign, transfer, pledge or hypothecate this Note at any time in Holder’s sole and absolute discretion.

8. Maximum Rate. All agreements which either are now or which shall become agreements between Debtor and Holder are expressly limited so that in no contingency or event whatever, whether by reason of deferment or advancement of the indebtedness represented by this Convertible Note, acceleration of the maturity date of this Convertible Note, or otherwise, shall the amount paid or agreed to be paid to Holder for the use, forbearance or detention of the indebtedness evidenced by this Convertible Note exceed the maximum amount of interest permissible under applicable law. If at any time, from any circumstance whatsoever, fulfillment of any provision of this Convertible Note or any other agreement between Debtor and Holder shall result in or involve payments or performance which would exceed the maximum legal interest rate, then ipso facto, the obligation to be fulfilled shall be reduced so as not to exceed such maximum legal interest rate.

9. Waiver. No delay or omission on the part of any holder hereof in exercising any right or option herein given to such holder shall impair such right or option to be considered as a waiver thereof or acquiescence in any default hereunder. Debtor hereby waives any applicable statute of limitations, presentment, demand for payment, protest and notice of dishonor.

10. Attorney’s Fees. In the event of any dispute, action, or other proceeding brought by either party against the other under this Convertible Note, the prevailing party shall be entitled to recover all costs and expenses incurred in connection with such dispute, action, or other proceeding, including, without limitation, the fees and costs of its attorneys, whether or not such dispute, action, or other proceeding proceeds to formal resolution or judgment.

11. Cumulative. Holder's rights and remedies under this Convertible Note and applicable law shall be cumulative and not in the alternative.

12. Governing Law and Venue. This Convertible Note is and shall be governed by and construed and enforced in accordance with the laws of the State of California without application of conflict of laws principles. Sole and proper venue and jurisdiction for any dispute arising out of or relating to this Convertible Note shall be San Diego County Superior Court in San Diego, California.

13. Successors. The provisions of this Convertible Note shall inure to the benefit of Holder's successors and assigns, and are binding on Debtor's successors.

14. Time of Essence. Time is of the essence under this Convertible Note.

15. Severability. Should any one or more of the provisions of this Note be determined to be illegal or unenforceable, such provision(s) shall (i) be modified to the minimum extent necessary to render it valid and enforceable, or (ii) if it cannot be so modified, be deemed not to be a part of this Note and shall not affect the validity or enforceability of the remaining provisions.

[Signature Page Follows]

1

IN WITNESS WHEREOF the parties have entered into this Convertible Note as of the date first above written.

DEBTOR:	HOLDER:
Neuropathix, Inc.,	[________________________],
a Delaware corporation	a [_______________________]
By: __________________	By: _______________________
Dean Petkanas, CEO	[__________________________]

2

ATTACHMENT 1

CONVERSION NOTICE

Neuropathix, Inc.

Date: __________________

Attn: Dean Petkanas, CEO

CONVERSION NOTICE

Holder hereby gives notice to Neuropathix, Inc., a Delaware corporation (the “Company”), pursuant to that certain Convertible Promissory Note, face value $50,000 dated March 21, 2022, made by the Company in favor of Holder (the “Note”), that Holder elects to convert the portion of the Note balance set forth below into fully paid and non-assessable shares of the Company’s regular common stock as of the date of conversion specified below. Said conversion shall be based on the Conversion Price set forth below.

A.

Date of conversion: __________________________

B.

Conversion Amount: _________________________

C.

Conversion Price: ____________________________

D.

Conversion Shares: ___________________________ (B divided by C)

E.

Remaining Outstanding Balance of Note: $____________________ including interest accrued thereon of $_____________ as of the date of this Conversion Notice.

Sincerely,

3

EX-101.SCH 3 nptx-20220321.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 4 nptx-20220321_lab.xml XBRL LABEL FILE Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] EX-101.PRE 5 nptx-20220321_pre.xml XBRL PRESENTATION FILE XML 6 R1.htm IDEA: XBRL DOCUMENT

Cover	Mar. 21, 2022
Cover [Abstract]
Document Type	8-K
Amendment Flag	false
Document Period End Date	Mar. 21, 2022
Entity File Number	000-55657
Entity Registrant Name	NEUROPATHIX, INC.
Entity Central Index Key	0001615999
Entity Tax Identification Number	46-2645343
Entity Incorporation, State or Country Code	DE
Entity Address, Address Line One	3805 Old Easton Road
Entity Address, City or Town	Doylestown
Entity Address, State or Province	PA
Entity Address, Postal Zip Code	18902
City Area Code	(858)
Local Phone Number	883-2642
Written Communications	false
Soliciting Material	false
Pre-commencement Tender Offer	false
Pre-commencement Issuer Tender Offer	false
Entity Emerging Growth Company	true
Elected Not To Use the Extended Transition Period	false

XML 7 nptx032422form8k_htm.xml IDEA: XBRL DOCUMENT 0001615999 2022-03-21 2022-03-21 iso4217:USD shares iso4217:USD shares 0001615999 false 8-K 2022-03-21 NEUROPATHIX, INC. DE 000-55657 46-2645343 3805 Old Easton Road Doylestown PA 18902 (858) 883-2642 false false false false true false EXCEL 8 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 9 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 10 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 11 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.1 html 1 20 1 false 0 0 false 3 false false R1.htm 00000001 - Document - Cover Sheet http://neuropathix.com/role/Cover Cover Cover 1 false false All Reports Book All Reports nptx032422form8k.htm ex10_1.htm nptx-20220321.xsd nptx-20220321_lab.xml nptx-20220321_pre.xml http://xbrl.sec.gov/dei/2021q4 true false JSON 13 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "nptx032422form8k.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "inline": { "local": [ "nptx032422form8k.htm" ] }, "labelLink": { "local": [ "nptx-20220321_lab.xml" ] }, "presentationLink": { "local": [ "nptx-20220321_pre.xml" ] }, "schema": { "local": [ "nptx-20220321.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd", "https://xbrl.sec.gov/country/2021/country-2021.xsd", "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd" ] } }, "elementCount": 59, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2021q4": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 20, "memberCustom": 0, "memberStandard": 0, "nsprefix": "NPTX", "nsuri": "http://neuropathix.com/20220321", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "b", "span", "p", "body", "html" ], "baseRef": "nptx032422form8k.htm", "contextRef": "From2022-03-21to2022-03-21", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00000001 - Document - Cover", "role": "http://neuropathix.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "b", "span", "p", "body", "html" ], "baseRef": "nptx032422form8k.htm", "contextRef": "From2022-03-21to2022-03-21", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://neuropathix.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://neuropathix.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AnnualInformationForm": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.", "label": "Annual Information Form" } } }, "localname": "AnnualInformationForm", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://neuropathix.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditedAnnualFinancialStatements": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.", "label": "Audited Annual Financial Statements" } } }, "localname": "AuditedAnnualFinancialStatements", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://neuropathix.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://neuropathix.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CountryRegion": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Region code of country", "label": "Country Region" } } }, "localname": "CountryRegion", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://neuropathix.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://neuropathix.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAccountingStandard": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.", "label": "Document Accounting Standard" } } }, "localname": "DocumentAccountingStandard", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://neuropathix.com/role/Cover" ], "xbrltype": "accountingStandardItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r11", "r13", "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://neuropathix.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://neuropathix.com/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://neuropathix.com/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://neuropathix.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentPeriodStartDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.", "label": "Document Period Start Date" } } }, "localname": "DocumentPeriodStartDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://neuropathix.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r12" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://neuropathix.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentRegistrationStatement": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a registration statement.", "label": "Document Registration Statement" } } }, "localname": "DocumentRegistrationStatement", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://neuropathix.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentShellCompanyEventDate": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "Date of event requiring a shell company report.", "label": "Document Shell Company Event Date" } } }, "localname": "DocumentShellCompanyEventDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://neuropathix.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentShellCompanyReport": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.", "label": "Document Shell Company Report" } } }, "localname": "DocumentShellCompanyReport", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://neuropathix.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r15" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://neuropathix.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://neuropathix.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated by Reference [Text Block]" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://neuropathix.com/role/Cover" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://neuropathix.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://neuropathix.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://neuropathix.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://neuropathix.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://neuropathix.com/role/Cover" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://neuropathix.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://neuropathix.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.", "label": "Entity Bankruptcy Proceedings, Reporting Current" } } }, "localname": "EntityBankruptcyProceedingsReportingCurrent", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://neuropathix.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://neuropathix.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://neuropathix.com/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://neuropathix.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://neuropathix.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r19" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Elected Not To Use the Extended Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://neuropathix.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://neuropathix.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://neuropathix.com/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://neuropathix.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r16" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://neuropathix.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityPrimarySicNumber": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.", "label": "Entity Primary SIC Number" } } }, "localname": "EntityPrimarySicNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://neuropathix.com/role/Cover" ], "xbrltype": "sicNumberItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://neuropathix.com/role/Cover" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://neuropathix.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://neuropathix.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://neuropathix.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://neuropathix.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://neuropathix.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [ "r17" ], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://neuropathix.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_Extension": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Extension number for local phone number.", "label": "Extension" } } }, "localname": "Extension", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://neuropathix.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://neuropathix.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://neuropathix.com/role/Cover" ], "xbrltype": "trueItemType" }, "dei_OtherReportingStandardItemNumber": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.", "label": "Other Reporting Standard Item Number" } } }, "localname": "OtherReportingStandardItemNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://neuropathix.com/role/Cover" ], "xbrltype": "otherReportingStandardItemNumberItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r7" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://neuropathix.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r8" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://neuropathix.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://neuropathix.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_Security12gTitle": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(g) registered security.", "label": "Title of 12(g) Security" } } }, "localname": "Security12gTitle", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://neuropathix.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://neuropathix.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SecurityReportingObligation": { "auth_ref": [ "r9" ], "lang": { "en-us": { "role": { "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.", "label": "Security Reporting Obligation" } } }, "localname": "SecurityReportingObligation", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://neuropathix.com/role/Cover" ], "xbrltype": "securityReportingObligationItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r10" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://neuropathix.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://neuropathix.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r18" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://neuropathix.com/role/Cover" ], "xbrltype": "booleanItemType" } }, "unitCount": 3 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r10": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r11": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310" }, "r12": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a" }, "r13": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f" }, "r14": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f" }, "r15": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r16": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r17": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "405" }, "r18": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" }, "r19": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r5": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "g" }, "r6": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12, 13, 15d" }, "r7": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r8": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r9": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "15", "Subsection": "d" } }, "version": "2.1" } ZIP 14 0001607062-22-000204-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001607062-22-000204-xbrl.zip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